Pharmacogenetics

Pharmacogenetics is an innovative field that specializes in the study of the role of genetics in drug response. The branch of pharmacology deals with the study of variations in an individual's DNA sequences, which may predict his or her response to prescribed drugs. Pharmacogenetics is important because it can help doctors make better decisions in prescribing drugs, especially those that require precise dosing, such as chemotherapy drugs. Since people's genetic makeups are different, some may be more sensitive to certain types of drugs than others. Pharmacogenetics can therefore identify such individuals and recommend alternative drugs or adjust doses to ensure maximum efficacy and safety. One vital aspect of pharmacogenetics is the identification of genetic mutations that links to drug toxicity. Genetic testing can determine if a patient carries known mutations that could increase his or her susceptibility to drug toxicity. As a result, such individuals might not be prescribed the specific drug. This reduces the likelihood of harmful side effects and can save lives. Pharmacogenetics is also an essential tool in drug development. It helps researchers develop new drugs that target specific genetic conditions, leading to more effective treatments. By identifying genetic markers that correlate with drug response, researchers can design drugs that target specific genes, reducing the potential for harmful side effects. In summary, pharmacogenetics is a crucial field in advanced pharmaceutical science and technology that helps us understand how genetic variations can influence our response to medications. It enables us to achieve more precise and personalized treatment plans and enhance drug safety, efficacy and development.

← Journal of Advanced Pharmaceutical Science And Technology

Related Articles

4 journal(s) found

Advanced Pharmaceutical Science And Technology

ISSN: 2328-0182
Type: Open Access Journal
Editor-in-Chief: Rajiv Kumar, Northeastern University & DFCI Harvard Medical School.
The journal aims to cover the latest outstanding developments and research being done in the world, thus ensuring its scientific priority and significance in the field of Pharmaceutical Science and Technology. We expect the field to grow beyond the current developments. We aim for the best.

Hematology and Oncology Research

ISSN: 2372-6601
Type: Open Access Journal
Editor-in-Chief: Krzysztof Roszkowski, Department of Oncology F. Lukaszczyk Oncology Center Nicolaus Copernicus University
Hematology is a branch of medicine concerning the study of blood, the blood-forming organs, and blood diseases. The word "heme" comes from the Greek for blood. Oncology is a branch of medicine that deals with prevention, diagnosis and treatment of cancer. It is very important for oncologists to keep updated of the latest advancements in oncology.

International Journal of Personalized Medicine

ISSN: Coming Soon
Type: Open Access Journal
Editor-in-Chief: Tarek Magdy Mohamed, Northwestern University, Department of Pharmacology and center of pharmacogenomics.
International Journal of Personalized Medicine aims to provide a personalized therapeutic strategy by considering factors influencing the response. These factors include patient related specific information. Applications and strategies need to be developed in order to improvise the existing treatment methods and put it into practical use. Personali

Implementation science

ISSN: Coming Soon
Type: Open Access Journal
Editor: Md. Maniruzzaman, Biostatistician, The JiVitA Project of John Hopkins University. 
Implementation science is the examination of techniques to support the acceptance and assimilation of evidence-based operations, interventions and strategies into paced health care and public health. JIS plays a prominent role in determining barriers to, and enablers of, effective comprehensive health programming and policymaking, and advantaging